EV/EBITDA
-27.45
+0.66+2.35%
Fri, 29 Nov 2024 19:13:06 GMT
Summary:
MoonLake Immunotherapeutics EV/EBITDA is currently -27.45, with a rise of +0.66 (+2.35%) during the most recent trading day. Over the past year, it has increased by +12.20 (+30.77%). MLTX EV/EBITDA is now -980.71% below its all-time high of -2.54.MLTX EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
MLTX EV/EBITDA Performance
PeriodPeriod | EV/EBITDAEV/EBITDA |
---|---|
todaytoday | +2.4% |
1 m1 month | -11.7% |
3 m3 months | +18.7% |
6 m6 months | +18.8% |
ytdytd | +53.6% |
1 y1 year | +30.8% |
5 y5 years | - |
MLTX EV/EBITDA High & Low
PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
---|---|---|---|---|---|
1 m | 1 month | -23.55 | -16.6% | -28.16 | +2.5% |
3 m | 3 months | -23.43 | -17.2% | -40.25 | +31.8% |
6 m | 6 months | -23.43 | -17.2% | -40.25 | +31.8% |
1 y | 1 year | -23.43 | -17.2% | -63.12 | +56.5% |
3 y | 3 years | -2.54 | -980.7% | -63.12 | +56.5% |
5 y | 5 years | -2.54 | -980.7% | -63.12 | +56.5% |
alltime | all time | -2.54 | -980.7% | -63.12 | +56.5% |
MoonLake Immunotherapeutics EV/EBITDA History
Date | Value |
---|---|
2024 | -27.45(-53.6%) |
Date | Value |
---|---|
2023 | -59.22(+895.3%) |
2022 | -5.95 |
FAQ
- What is MoonLake Immunotherapeutics EV/EBITDA?
- What is the all time high EV/EBITDA for MoonLake Immunotherapeutics?
- What is MLTX EV/EBITDA year-to-date change?
- What is MoonLake Immunotherapeutics EV/EBITDA year-on-year change?
What is MoonLake Immunotherapeutics EV/EBITDA?
The current EV/EBITDA of MLTX is -27.45
What is the all time high EV/EBITDA for MoonLake Immunotherapeutics?
MoonLake Immunotherapeutics all-time high EV/EBITDA is -2.54
What is MLTX EV/EBITDA year-to-date change?
MoonLake Immunotherapeutics EV/EBITDA has changed by +31.77 (+53.65%) since the beginning of the year
What is MoonLake Immunotherapeutics EV/EBITDA year-on-year change?
Over the past year, MLTX EV/EBITDA has changed by +12.20 (+30.77%)